BDNF and breast carcinoma: Therefore, this systematic review aims to analyze BDNF and/or cytokines as potential biomarkers of cognitive dysfunction associated with breast cancer and its treatments (e.g., chemotherapy), as well as to examine the response of these biomarkers to various interventions intended to mitigate such effects in animal models.